0001209191-23-039426.txt : 20230623 0001209191-23-039426.hdr.sgml : 20230623 20230623164046 ACCESSION NUMBER: 0001209191-23-039426 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230622 FILED AS OF DATE: 20230623 DATE AS OF CHANGE: 20230623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Croarkin Richard CENTRAL INDEX KEY: 0001641815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 231038322 MAIL ADDRESS: STREET 1: C/O AERIE PHARMACEUTICALS, INC. STREET 2: 2030 MAIN STREET, SUITE 1500 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-22 0 0001539029 Clearside Biomedical, Inc. CLSD 0001641815 Croarkin Richard C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 1 0 0 0 0 Stock Option (right to buy) 1.31 2023-06-22 4 A 0 30000 0.00 A 2033-06-21 Common Stock 30000 30000 D The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2023-06-23